Nextage Therapeutics (XTAE:NXTG) Interest Expense : ₪-0.05 Mil (TTM As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

What is Nextage Therapeutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Nextage Therapeutics's interest expense for the six months ended in Dec. 2023 was ₪ 0.11 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-0.05 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Nextage Therapeutics's Operating Income for the six months ended in Dec. 2023 was ₪ -1.72 Mil. Nextage Therapeutics's Interest Expense for the six months ended in Dec. 2023 was ₪ 0.11 Mil. Nextage Therapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Nextage Therapeutics Interest Expense Historical Data

The historical data trend for Nextage Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextage Therapeutics Interest Expense Chart

Nextage Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.13

-0.16

-0.03

-0.05

Nextage Therapeutics Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial									-0.14	-0.06	0.03	-0.16	0.11

Nextage Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪-0.05 Mil.

Nextage Therapeutics (XTAE:NXTG) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Nextage Therapeutics's Interest Expense for the six months ended in Dec. 2023 was ₪0.11 Mil. Its Operating Income for the six months ended in Dec. 2023 was ₪-1.72 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was ₪0.07 Mil.

Nextage Therapeutics's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

The higher the ratio, the stronger the company's financial strength is.

Nextage Therapeutics (XTAE:NXTG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nextage Therapeutics Ltd (XTAE:NXTG) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bio-Light, Kiryat Atidim 7, Entrance 1, 2rd Floor, Tel Aviv, ISR, 61581

Website

http://www.m-medic.com

Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.

Nextage Therapeutics (XTAE:NXTG) Headlines

From GuruFocus

First Trust Global Portfolios Limited Announces Name Changes for Certain Sub-Funds of First Trust Global Funds plc

By Business Wire Business Wire • 01-29-2021